期刊文献+

外源性p53基因导入不同时限后联合放疗对肺腺癌细胞A549的影响 被引量:1

Effects of Different Durations of Wild-type p53 Gene Introduction Combined with Radiotherapy in Lung Adenocarcinoma Cell Line A549
下载PDF
导出
摘要 目的探讨重组人腺病毒p53导入不同时限后联合放疗对A549肺腺癌细胞生长抑制、凋亡和p53蛋白表达的影响。方法将外源性p53基因导入人肺腺癌细胞株A549中,加药后即刻、3、6、24和48h联合射线照射(单次4Gy)。MTT检测细胞生长抑制,流式细胞仪检测细胞凋亡,Western blot检测野生型p53蛋白的表达情况。结果加药6、24和48h后放疗组与加药未放疗组、加药即刻放疗组和加药3h后放疗组比较,A549细胞生长抑制率、凋亡率及p53蛋白表达水平均显著增高(P<0.05)。结论为获得对肿瘤细胞的最大杀伤作用,可将放疗时间选定在导入重组人腺病毒p53后6~48h内。 Objective To explore the effects of different durations of recombinant human adenovirus p53 introduction combined with radiotherapy on cell growth inhibition,cell apoptosis,and p53 protein expression in lung adenocarcinoma cell line A549.Methods Wild-type p53 gene was injected into human lung adenocarcinoma cell line A549.A549 cells were exposed to radiation(4 Gy)immediately,3,6,24,and 48 hours after p53 gene introduction.The cell growth inhibition,cell apoptosis,and expression of p53 protein were determined by MTT assay,flow cytometry,and Western blot,respectively.Results Compared with A549 cells unexposed to radiation and those exposed to radiation immediately and 3 hours after p53 gene introduction,the inhibitory rate,apoptotic rate,and expression level of p53 protein were significantly higher in cells exposed to radiation 6,24,and 48 hours after p53 gene introduction(all P〈0.05).Conclusion To gain the maximum cell-killing effect,the radiotherapy should be performed 6 to 48 hours after the introduction of adenovirus p53 gene.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2010年第7期539-541,545,共4页 Journal of China Medical University
关键词 P53基因 放射治疗 基因治疗 p53 gene radiotherapy gene therapy
  • 相关文献

参考文献2

二级参考文献18

  • 1张珊文,肖绍文,刘长清,孙艳,苏星,李东明,徐刚,蔡勇,朱广迎,徐博,吕有勇.重组人p53腺病毒注射液联合放射线治疗头颈鳞癌的Ⅱ期临床试验[J].中华医学杂志,2003,83(23):2023-2028. 被引量:69
  • 2官泳松,刘源,贺庆,杨林,李肖,孙龙.p53基因(今又生~)联合支气管动脉化疗治疗肺癌15例近期疗效观察[J].中国介入影像与治疗学,2005,2(6):405-408. 被引量:12
  • 3Zhang L, Yu D, Hu M, et al. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression. Cancer Res, 2000,60:3655-3661.
  • 4Zhang EP, Lian PG, Cai KL,et al. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys, 1989,16:301-305.
  • 5Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys, 1992,23:261-270.
  • 6Kanegae Y, Makimura M,Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol, 1994,47:157-166.
  • 7Brand K, Klocke R, Possling A, et al. Induction of apoptosis and G2/M arrest by infection with replication-deficient adenovirus at high multiplicity of infection. Gene Ther, 1999, 6: 1054-1063.
  • 8Li JH, Lax SA, Kim J, et al. The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 1999, 43:607-616.
  • 9Clayman GL, el-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol, 1998,16:2221-2232.
  • 10Clayman GL, Frank DK, Bruso PA, et al. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers. Clin Cancer Res, 1999, 5:1715-1722.

共引文献27

同被引文献14

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CACaneerJ C1in,2011,61(2):69-90.
  • 2Center MM, Jemal A, Ward E. International trends in colorectal can- cer incidence rates [ J ]. Cancer Epidemiol Biomarkers Prey, 2009,18 (6) : 1688-1694.
  • 3Liu Y, Shete S, Wang LE, et al. Gamma-radiation sensitivity and polymorphisms in RAD51L1 modulate glioma risk [J]. Carcinogene- sis,2010,31 (10) : 1762-1769.
  • 4Du LQ, Wang Y, Wang H, et al. Knockdown of Rad51 expression in- duces radiation and cherno- sensitivity in osteosarcoma cells [J]. Med 0ncol,2011,28(4) : 1481-1487.
  • 5Uphoff S, Kapanidis AN. Studying the organization of DNA repair by single- cell and single- molecule imaging [J]. DNA Repair (Amst), 2014,20 (100) : 32-40.
  • 6Abbotts R, Thompson N, Madhusudan S. DNA repair in cancer: emerging targets for personalized therapy [J ]. Cancer Manag Res, 2014,6 : 77-92.
  • 7Park SW, Yoo NJ, Lee SH. Mutational analysis of mouonucleotide repeats in XRCC2 and XRCC6 in cancers with microsatellite insta- bility ~J ]. Pathology, 2011,43 ( 1 ) : 78-79.
  • 8Zheng Z, Ng WL, Zhang X, et al. RNAi-mediated targeting of non- coding and coding sequences in DNA repair gene messages effi- ciently radiosensitizes human tumor cells[J~. Cancer Res, 2012,72 (5):1221-1228.
  • 9Ma W, Ma L, Zhe H, et al. Detection of esophageal squamous cell carcinoma by cathepsin B activity in nude mice [J]. PEoS One, 2014,9(3) :e92351.
  • 10郭阳.DNA链间交联的修复与辐射敏感性[J].国际放射医学核医学杂志,2007,31(6):371-372. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部